- 2020
- Press releases - 15.06.2020
COVID-19: Vaccine Research at Inserm
Developing an effective and safe vaccine is one of the priority objectives in the fight to contain the COVID-19 pandemic. At Inserm, a dozen teams are involved in vaccine research projects. In particular, three initiatives have recently been selected by France’s Ministry of Higher Education, Research and Innovation on the advice of the COVID-19 Analysis, Research and Expertise Committee (CARE) and Inserm’s REACTing consortium, in order to receive special support and thus accelerate research.
- Press releases - 12.06.2020
Cardiac arrest outside the hospital during the peak of the COVID-19 epidemic: studies highlight pulmonary embolism as the main determinant
Des investigateurs français de l’Institut médico-légal de Paris, de l’Inserm, du service de radiologie de l’hôpital Sainte-Anne/GHU Paris, du département d’anesthésie-réanimation des hôpitaux de l’AP-HP Saint-Louis et Lariboisière, d’Université de Paris, et du CNRS ont fait l’hypothèse que les arrêts cardiaques en dehors de l’hôpital pendant le pic de la pandémie de Covid-19 pourraient être en partie dus à des embolies pulmonaires massives. Le détail de ces travaux a été publié le 28 mai 2020 dans l’European Journal of Heart Failure.
- Press releases - 11.06.2020
Inflammatory Bowel Disease: Immune Cells Spearheading the Cure
Inflammations of the intestine affect many patients, often with reduced therapeutic prospects. The role of iron in these inflammatory processes is increasingly well documented, opening up new avenues of treatment. A collaborative study shows that the hormone that regulates iron levels in the body is produced by immune cells during inflammation of the intestine, and that it helps repair damage to the intestinal mucosa.
- Press releases - 09.06.2020
Repetitive negative thinking linked to dementia risk
Persistently engaging in negative thinking patterns may raise the risk of Alzheimer’s disease, finds a new UCL-led study.
- Press releases - 08.06.2020
Eliminating Senescent Cells Is Not the Answer to a Long and Healthy Life
Until now considered highly promising in the fight against aging, the therapeutic strategy of eliminating the senescent cells that accumulate in the body is being challenged by the team of Dmitry Bulavin, Inserm researcher at the Institute for Research on Cancer and Aging of Nice (Inserm/CNRS/Université Côte d’Azur).
- Press releases - 05.06.2020
Covid-19: Publication of a prospective observational study in the journal BMJ in children with hyper-inflammatory syndrome related to Kawasaki disease
characteristics of children and adolescents hospitalized in a context of Kawasaki disease-like syndrome in a COVID-19 epidemic context, with a systemic hyper-inflammatory expression.
- Press releases - 05.06.2020
COVID-19 and the Environment: A European Program Coordinated by Inserm gives its recommendations
Launched in 2019, the primary objective of the Health Environment Research Agenda for Europe (HERA) is to provide the European Commission with an environment, climate, and health research agenda for 2020-2030.
- Press releases - 28.05.2020
Paris and Its Suburbs: Twice as Many Cardiac Arrests During Lockdown
Indirect consequences of the COVID-19 pandemic on the healthcare system and the management of other diseases are beginning to emerge.
- Press releases - 28.05.2020
Tests for everyone, really?
Deconfinement is now well under way. At the heart of the system is a promise: massive testing of the population.
- Press releases - 27.05.2020
Hydroxychloroquine and azithromycin can have a deleterious impact on the cardiovascular system
Hydroxychloroquine and azithromycin can have a damaging impact on the cardiovascular system and are a life-threatening combination, according to large analysis from a World Health Organization (WHO) database of adverse drug reactions.